stockrow
Friday 6 November 2026
Export NEPH’s income statement to Excel — free account
Nephros Inc.
NEPH Healthcare Medical Instruments & Supplies
Nephros Inc.’s revenue for fiscal 2025 (year ended December 2025) was $18.8 million, up 32.7% from fiscal 2024.
- Revenue
- +18.0%
- EPS
- +66.7%
- Free cash flow
- −251.5%
Quarter to September 2026, against a year earlier
2.83
0.26
−8.41%
Follow NEPH
Alert me
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 6 | 4 | 3 | 1 | 6 | 2 | 6 | 3 |
P/E ratio |
46.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
(3.26) | (12.50) | (9.50) | (14.45) | 2.19 | 6.54 | (3.30) | (10.63) | (29.56) | (60.08) |
P/S ratio |
2.76 | 1.09 | 2.50 | 1.15 | 5.79 | 9.10 | 7.26 | 6.18 | 6.25 | 8.79 |
P/FCF ratio |
34.07 | 0.00 | 54.89 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
(26.46) | (34.59) | (34.61) | (36.49) | (16.79) | (14.31) | (32.16) | (34.93) | (79.01) | (152.37) |
Beneish M-Score |
(2.60) | (2.01) | (3.32) | (2.99) | (2.61) | (1.44) | (2.44) | (1.61) | (2.49) | (4.43) |
P/Operating CF |
225.16 | 11.86 | (150.31) | (58.61) | (176.44) | (51.05) | 206.16 | (66.52) | 13.28 | (38.64) |
P/B ratio |
5.08 | 1.80 | 4.26 | 1.29 | 4.01 | 5.00 | 9.76 | 5.17 | 12.21 | 30.59 |
Price to Tangible BV |
5.78 | 2.13 | 5.13 | 1.57 | 4.55 | 5.71 | 13.45 | 7.77 | 27.13 | 0.00 |
EV/Sales |
2.47 | 0.83 | 2.20 | 0.78 | 5.11 | 8.30 | 6.97 | 5.69 | 6.11 | 9.03 |
EV/EBITDA |
36.10 | 81.94 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
28.20 | (23.82) | 37.88 | (2.41) | (36.86) | (10.29) | (31.66) | (8.84) | (302.21) | (9.91) |
EV/FCF |
30.52 | (18.99) | 48.26 | (2.31) | (35.95) | (9.95) | (31.39) | (8.73) | (190.74) | (9.71) |
Quick Ratio |
2.82 | 3.55 | 2.75 | 3.48 | 3.60 | 7.26 | 2.15 | 2.24 | 1.63 | 0.77 |
Current Ratio |
4.06 | 5.31 | 3.98 | 5.85 | 5.70 | 11.44 | 3.42 | 3.08 | 2.04 | 1.41 |
Net Debt/EBITDA |
(4.20) | (26.29) | 3.12 | 0.91 | 2.29 | 1.82 | 1.01 | 0.97 | 0.29 | (0.21) |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.01% | 0.56% | 4.57% | 10.09% | 17.37% | 33.41% | 31.29% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 | 0.15 | 0.27 | 0.85 | 1.26 |
Asset Turnover |
1.51 | 1.23 | 1.25 | 0.70 | 0.57 | 0.57 | 0.93 | 0.73 | 0.99 | 0.70 |
Operating CF/Net income |
1.38 | (6.65) | (0.53) | 0.44 | 0.35 | 1.45 | 0.67 | 1.08 | 0.10 | 0.70 |
Capex/Depreciation |
0.00 | (0.36) | (0.35) | (0.39) | (0.14) | (1.15) | (0.07) | 0.00 | 0.00 | (0.16) |
Interest Coverage |
1,146.00 | 6.00 | (796.50) | (216.75) | (79.32) | (38.86) | (16.18) | (17.53) | (7.37) | (16.68) |
| 12.71% | 0.87% | (18.27%) | (62.48%) | (27.09%) | (40.98%) | (47.21%) | (77.78%) | (61.83%) | (182.05%) | |
| 9.61% | 0.64% | (13.78%) | (51.53%) | (22.72%) | (31.63%) | (30.83%) | (43.78%) | (21.12%) | (91.22%) | |
ROIC |
14.92% | 0.08% | (24.58%) | (51.63%) | (25.81%) | (32.70%) | (41.99%) | (46.53%) | (99.30%) | (149.05%) |
Return on Tangible Assets |
13.95% | 1.07% | (24.44%) | (105.99%) | (36.29%) | (33.74%) | (57.46%) | (60.64%) | (40.65%) | (690.66%) |
Average Days of Receivables |
46.90 | 45.90 | 38.35 | 47.06 | 58.62 | 58.15 | 36.91 | 87.22 | 80.11 | 61.04 |
Research and Development Expense of Revenue |
7.13% | 6.40% | 6.13% | 12.58% | 14.66% | 32.23% | 29.90% | 27.06% | 26.31% | 46.51% |
Selling, General and Administrative Expense of Revenue |
47.90% | 54.20% | 62.59% | 76.12% | 70.42% | 75.53% | 59.21% | 79.43% | 86.58% | 123.02% |
Intangible Assets out of Total Assets |
0.09 | 0.12 | 0.12 | 0.14 | 0.10 | 0.10 | 0.18 | 0.22 | 0.22 | 0.47 |
Share Based Compensation of Revenue |
1.58% | 1.08% | 7.39% | 9.84% | 12.32% | 9.10% | 12.89% | 17.32% | 20.27% | 25.73% |
Graham Net Nets |
0.15 | 0.37 | 0.14 | 0.54 | 0.18 | 0.16 | 0.06 | 0.13 | 0.03 | (0.04) |
Graham Number |
1.51 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
2.17% | 0.00% | (4.37%) | (64.05%) | (6.95%) | (6.06%) | (4.42%) | (10.53%) | (4.08%) | (16.16%) |
Free Cash Flow Yield |
2.94% | (3.99%) | 1.82% | (29.49%) | (2.46%) | (9.17%) | (3.06%) | (10.55%) | (0.51%) | (10.57%) |
Revenue per Share |
1.77 | 1.35 | 1.37 | 0.97 | 1.02 | 0.94 | 1.37 | 0.83 | 0.65 | 0.43 |
Operating CF per Share |
0.16 | (0.05) | 0.08 | (0.31) | (0.14) | (0.76) | (0.30) | (0.53) | (0.01) | (0.39) |
Capex per Share |
0.00 | 0.00 | (0.01) | (0.01) | 0.00 | (0.03) | 0.00 | 0.00 | 0.00 | (0.01) |
Free Cash Flow per Share |
0.16 | (0.05) | 0.07 | (0.33) | (0.14) | (0.79) | (0.30) | (0.53) | (0.01) | (0.40) |
Cash per Share |
0.51 | 0.36 | 0.41 | 0.35 | 0.70 | 0.91 | 0.55 | 0.67 | 0.38 | 0.06 |
Shareholders Equity per Share |
0.96 | 0.82 | 0.80 | 0.86 | 1.47 | 1.72 | 1.02 | 0.99 | 0.33 | 0.12 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.96 | 0.82 | 0.80 | 0.86 | 1.47 | 1.72 | 1.02 | 0.99 | 0.33 | 0.12 |
Free Cash Flow |
1.65 | (0.54) | 0.75 | (3.37) | (1.45) | (7.14) | (2.29) | (3.66) | (0.08) | (2.16) |
Working Capital |
8.46 | 6.74 | 6.29 | 6.85 | 11.24 | 13.83 | 5.87 | 5.52 | 1.94 | 0.37 |
Capital Expenditures |
— | (0.05) | (0.07) | (0.14) | (0.04) | (0.24) | (0.01) | — | — | (0.04) |
Net Current Asset Value |
7.78 | 5.67 | 4.90 | 6.14 | 10.73 | 12.22 | 4.36 | 4.41 | 0.78 | (0.75) |
EV/EBIT |
40.48 | 1,952.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.03 | 0.00 | 0.00 | 0.00 | 0.02 |
Price to Operating Income |
45.19 | 2,578.63 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
1.31 | 0.85 | 1.41 | 3.03 | 3.50 | 0.71 | 2.47 | 2.16 | 6.42 | 4.04 |
Cash ROIC |
10.54% | (4.39%) | 5.94% | (26.93%) | (6.66%) | (28.95%) | (17.58%) | (27.72%) | (1.32%) | (119.37%) |
Accounts Receivable Turnover |
8.96 | 8.64 | 10.24 | 6.82 | 6.80 | 7.11 | 8.60 | 5.18 | 6.22 | 5.91 |
Accounts Payable Turnover |
9.17 | 7.15 | 7.23 | 5.06 | 5.22 | 5.28 | 4.74 | 2.91 | 2.08 | 1.66 |
Inventory Turnover |
2.45 | 2.14 | 2.07 | 1.38 | 0.94 | 0.93 | 1.92 | 1.96 | 2.63 | 1.92 |
Average Days of Payables |
46.57 | 43.55 | 54.63 | 51.51 | 106.22 | 42.32 | 82.36 | 122.84 | 209.81 | 208.11 |
Days of Inventory on Hand |
164.67 | 175.49 | 154.56 | 219.46 | 355.29 | 530.69 | 220.03 | 273.90 | 162.17 | 170.40 |
Average Receivables |
2.10 | 1.64 | 1.39 | 1.46 | 1.50 | 1.20 | 1.20 | 1.10 | 0.61 | 0.39 |
Average Payables |
0.78 | 0.76 | 0.81 | 1.04 | 0.88 | 0.69 | 0.90 | 0.85 | 0.73 | 0.62 |
Average Inventory |
2.92 | 2.54 | 2.81 | 3.81 | 4.88 | 3.93 | 2.21 | 1.27 | 0.58 | 0.54 |
Average Assets |
12.43 | 11.54 | 11.43 | 14.32 | 18.08 | 15.07 | 11.09 | 7.77 | 3.83 | 3.32 |
Average Common Equity |
9.39 | 8.47 | 8.62 | 11.82 | 15.16 | 11.63 | 7.24 | 4.37 | 1.31 | 1.67 |
Columns are period end dates · fundamentals updated 5 Nov 2026